Most mesothelioma marketing hands your intake team a list and wishes them luck. Recycled names, suspected diagnoses and claimants another firm already called. Nexus Legal Group takes a different approach. We start with people actively researching mesothelioma, asbestos exposure and FDA-approved treatments right now, and we finish with a signed file.
Most mesothelioma marketing hands your intake team a list and wishes them luck. Recycled names, suspected diagnoses and claimants another firm already called.
Nexus Legal Group takes a different approach. We start with people actively researching mesothelioma, asbestos exposure and FDA-approved treatments right now, and we finish with a signed file.
Real intent, not inventory. Our platform identifies households searching treatments like Alimta and Opdivo, a strong signal of an active diagnosis.
Your criteria, in writing. Biopsy-confirmed diagnosis, recent diagnosis date, exposure before the mid-1980s and no other attorney retained.
High-risk work histories. Navy, shipyards, steel and paper mills, construction, boiler rooms, auto repair and more.
Multichannel follow-up. Email, display, preroll video, social and retargeting keep your firm visible while families decide.
New Client Matters. Complete files with your engagement documents already signed, ready for attorney review.
We limit the number of participating firms to protect claimant flow and file quality.
Book 15 minutes to review criteria and volume: calendly.com/nexuslegalgroup
Qualified firms can also be introduced to our funding source: nexuslegal.group/programs/attorney-funding
Rob Parker
Managing Partner, Nexus Legal Group
rob@nexuslegal.group | 855-925-1035
nexuslegal.group